The Anti-Cancer Multikinase Inhibitor Sorafenib Impairs Cardiac Contractility by Reducing Phospholamban Phosphorylation and Sarcoplasmic Calcium Transients.

Sci Rep · 2018 · PMC5871797 · PMID 29593308

Europe PMC DOI

hedged sentence

0.0980

closest p · 2.0× alpha

0.0980

boldest claim

The sentences

did not reach statistical significancep = 0.098so close (0.05 < p ≤ 0.1)

5a ), while decreased CaMKII-dependent phosphorylation at threonine 17 did not reach statistical significance (p = 0.098, n = 6 per group; Fig. 5b ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.